These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29261730)

  • 1. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
    Renault V; Tost J; Pichon F; Wang-Renault SF; Letouzé E; Imbeaud S; Zucman-Rossi J; Deleuze JF; How-Kit A
    PLoS One; 2017; 12(12):e0189334. PubMed ID: 29261730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome.
    Žilina O; Koltšina M; Raid R; Kurg A; Tõnisson N; Salumets A
    BMC Genomics; 2015 Sep; 16(1):703. PubMed ID: 26376747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
    Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
    Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
    Ching HC; Naidu R; Seong MK; Har YC; Taib NA
    Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
    Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
    BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Human Genome-Wide CNV, LOH and UPD by Targeted Sequencing of Selected Regions.
    Li W; Xia Y; Wang C; Tang YT; Guo W; Li J; Zhao X; Sun Y; Hu J; Zhen H; Zhang X; Chen C; Shi Y; Li L; Cao H; Du H; Li J
    PLoS One; 2014; 10(4):e0123081. PubMed ID: 25919136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.
    Chen W; Ding J; Jiang L; Liu Z; Zhou X; Shi D
    Funct Integr Genomics; 2017 Jan; 17(1):85-96. PubMed ID: 27896456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
    Shen W; Szankasi P; Durtschi J; Kelley TW; Xu X
    Methods Mol Biol; 2019; 1908():113-124. PubMed ID: 30649724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide identification of copy neutral loss of heterozygosity reveals its possible association with spatial positioning of chromosomes.
    Kim H; Suyama M
    Hum Mol Genet; 2023 Mar; 32(7):1175-1183. PubMed ID: 36349694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
    Xu X; Bryke C; Sukhanova M; Huxley E; Dash DP; Dixon-Mciver A; Fang M; Griepp PT; Hodge JC; Iqbal A; Jeffries S; Kanagal-Shamanna R; Quintero-Rivera F; Shetty S; Slovak ML; Yenamandra A; Lennon PA; Raca G
    Cancer Genet; 2018 Dec; 228-229():218-235. PubMed ID: 30344013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.
    Shen W; Paxton CN; Szankasi P; Longhurst M; Schumacher JA; Frizzell KA; Sorrells SM; Clayton AL; Jattani RP; Patel JL; Toydemir R; Kelley TW; Xu X
    J Clin Pathol; 2018 Apr; 71(4):372-378. PubMed ID: 29197855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated analysis tool for analyzing hybridization intensities and genotypes using new-generation population-optimized human arrays.
    Huang MC; Chuang TP; Chen CH; Wu JY; Chen YT; Li LH; Yang HC
    BMC Genomics; 2016 Mar; 17():266. PubMed ID: 27029637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.
    Poulain S; Roumier C; Galiègue-Zouitina S; Daudignon A; Herbaux C; Aiijou R; Lainelle A; Broucqsault N; Bertrand E; Manier S; Renneville A; Soenen V; Tricot S; Roche-Lestienne C; Duthilleul P; Preudhomme C; Quesnel B; Morel P; Leleu X
    Am J Hematol; 2013 Nov; 88(11):948-54. PubMed ID: 23861223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genome-wide detection of loss of heterozygosity and copy number variation in a human lung large cell carcinoma cell line by affymetrix single-nucleotide polymorphism array 500K.].
    Hu B; Chen J; Liu H; Wu H; Wu Z; Wang Y; Bai Y; Li Y; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2008 Jun; 11(3):327-32. PubMed ID: 20731928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAFFYS: An Integrated Tool for Comprehensive Analysis of Genomic Aberrations in Tumor Samples.
    Liu Y; Li A; Feng H; Wang M
    PLoS One; 2015; 10(6):e0129835. PubMed ID: 26111017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in molecular diagnostics of colorectal cancer by genomic arrays: proposal for a procedural shift in biological sampling and pathological report.
    Castorina S; Barresi V; Luca T; Privitera G; Musso N; Capizzi C; Condorelli DF
    Ital J Anat Embryol; 2010; 115(1-2):39-45. PubMed ID: 21072988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.